Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

4.44AUD
19 Dec 2014
Price Change (% chg)

$0.39 (+9.63%)
Prev Close
$4.05
Open
$4.11
Day's High
$4.45
Day's Low
$4.08
Volume
1,412,229
Avg. Vol
418,376
52-wk High
$6.13
52-wk Low
$3.64

MSB.AX

Chart for MSB.AX

About

Mesoblast Limited (Mesoblast) is a clinical development company leveraging its core technologies, which include the Mesenchymal Precursor Cell (MPC) technology platform for bone marrow and adipose tissue derived products, Dental Pulp Stem Cells (DPSCs), and expanded Hematopoietic Stem Cells (HSCs). The Company’s cardiovascular... (more)

Overall

Beta: 0.49
Market Cap (Mil.): $1,403.68
Shares Outstanding (Mil.): 324.18
Dividend: --
Yield (%): --

Financials

  MSB.AX Industry Sector
P/E (TTM): -- 151.53 38.61
EPS (TTM): -0.25 -- --
ROI: -9.58 -0.59 18.27
ROE: -13.47 -1.72 19.14
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: irasia.com
$12.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks